Order:
  1.  23
    Clinical Perspectives from Japan.Satoshi Kodama, Yumi Matsumura, Takahiro Hattori & Keiko Sato - 2015 - Asian Bioethics Review 7 (4):410-412.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  2.  15
    Standards of Conducts for Biostatisticians and Stem Cell Researchers: A Call for Self-formulated Aspirational Ethics Over Built-in Prohibitive Ethics.Keiko Sato & Mika Suzuki - 2022 - Science and Engineering Ethics 28 (2):1-20.
    We proposed the Standards of Conducts to provide a general framework that will serve as the basis for guiding each biostatistician and stem cell researcher to formulate their personal standards, rather than as rules with which they are required to comply. Given the responsibility and characteristics of their work, they are expected to maintain independence and work autonomously as professionals. Each of the Standards of Conducts comprises a preamble, mission and values to uphold, Standards of Conducts, and background. When one (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  3.  13
    Patient perspectives on research use of residual biospecimens and health information: On the necessity of obtaining societal consent by creating a governance structure based on value-sharing.Mayumi Yamanaka, Mika Suzuki & Keiko Sato - 2021 - Research Ethics 17 (1):103-119.
    Very few attempts have been made to survey patient opinions, particularly regarding the use of residual biospecimens and health information in research, to clarify their values. We conducted a questionnaire survey that targeted outpatients of a university hospital to gauge their awareness levels and understand patient perspectives on research that uses these items. Few patients felt that obtaining individual consent for each research study was necessary. Most patients expressed the view that researchers should be obligated to inform them about the (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark